These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 17484513

  • 21. Insulin-like growth factor-binding protein-1: a biochemical marker of endometrial response to progestin during hormone replacement therapy.
    Suvanto-Luukkonen E, Sundström H, Penttinen J, Kauppila A, Rutanen EM.
    Maturitas; 1995 Nov; 22(3):255-62. PubMed ID: 8746884
    [Abstract] [Full Text] [Related]

  • 22. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
    Bannink EM, van Doorn J, Stijnen T, Drop SL, de Muinck Keizer-Schrama SM.
    Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
    [Abstract] [Full Text] [Related]

  • 23. Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiol.
    Gravholt CH, Naeraa RW, Fisker S, Christiansen JS.
    J Clin Endocrinol Metab; 1997 Aug; 82(8):2570-7. PubMed ID: 9253336
    [Abstract] [Full Text] [Related]

  • 24. A switch from oral (2 mg/day) to transdermal (50 microg/day) 17beta-estradiol therapy increases serum insulin-like growth factor-I levels in recombinant human growth hormone (GH)-substituted women with GH deficiency.
    Janssen YJ, Helmerhorst F, Frölich M, Roelfsema F.
    J Clin Endocrinol Metab; 2000 Jan; 85(1):464-7. PubMed ID: 10634425
    [Abstract] [Full Text] [Related]

  • 25. Positive effects on cardiovascular and breast metabolic markers of oral estradiol and dydrogesterone in comparison with transdermal estradiol and norethisterone acetate.
    Campagnoli C, Colombo P, De Aloysio D, Gambacciani M, Grazioli I, Nappi C, Serra GB, Genazzani AR.
    Maturitas; 2002 Apr 25; 41(4):299-311. PubMed ID: 12034517
    [Abstract] [Full Text] [Related]

  • 26. Relations between sex hormones, sex hormone binding globulin, insulin-like growth factor-I and insulin-like growth factor binding protein-1 in post-menopausal breast cancer patients.
    Lønning PE, Helle SI, Johannessen DC, Adlercreutz H, Lien EA, Tally M, Ekse D, Fotsis T, Anker GB, Hall K.
    Clin Endocrinol (Oxf); 1995 Jan 25; 42(1):23-30. PubMed ID: 7534218
    [Abstract] [Full Text] [Related]

  • 27. Comparison of the metabolic effects of raloxifene and oral estrogen in postmenopausal and growth hormone-deficient women.
    Gibney J, Johannsson G, Leung KC, Ho KK.
    J Clin Endocrinol Metab; 2005 Jul 25; 90(7):3897-903. PubMed ID: 15855258
    [Abstract] [Full Text] [Related]

  • 28. Serum levels of insulin-like growth factor I and insulin-like growth factor-binding protein 1 correlate with serum free testosterone and sex hormone binding globulin levels in healthy young and middle-aged men.
    Erfurth EM, Hagmar LE, Sääf M, Hall K.
    Clin Endocrinol (Oxf); 1996 Jun 25; 44(6):659-64. PubMed ID: 8801037
    [Abstract] [Full Text] [Related]

  • 29. Estrogens exert route- and dose-dependent effects on insulin-like growth factor (IGF)-binding protein-3 and the acid-labile subunit of the IGF ternary complex.
    Kam GY, Leung KC, Baxter RC, Ho KK.
    J Clin Endocrinol Metab; 2000 May 25; 85(5):1918-22. PubMed ID: 10843175
    [Abstract] [Full Text] [Related]

  • 30. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM, Tiitinen A, Stenman UH, Seppälä M, Laatikainen T.
    Fertil Steril; 1991 May 25; 55(5):895-9. PubMed ID: 1708731
    [Abstract] [Full Text] [Related]

  • 31. Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
    Nugent AG, Leung KC, Sullivan D, Reutens AT, Ho KK.
    Clin Endocrinol (Oxf); 2003 Dec 25; 59(6):690-8. PubMed ID: 14974909
    [Abstract] [Full Text] [Related]

  • 32. Insulin, insulin-like growth factor-binding protein-1, and sex hormone-binding globulin in patients with Turner's syndrome: course over age in untreated patients and effect of therapy with growth hormone alone and in combination with oxandrolone.
    Haeusler G, Schmitt K, Blümel P, Plöchl E, Waldhör T, Frisch H.
    J Clin Endocrinol Metab; 1996 Feb 25; 81(2):536-41. PubMed ID: 8636264
    [Abstract] [Full Text] [Related]

  • 33. Effect of long-term treatment with raloxifene on mammary density in postmenopausal women.
    Lasco A, Gaudio A, Morini E, Morabito N, Nicita-Mauro C, Catalano A, Denuzzo G, Sansotta C, Xourafa A, Macrì I, Frisina N.
    Menopause; 2006 Feb 25; 13(5):787-92. PubMed ID: 16912660
    [Abstract] [Full Text] [Related]

  • 34. A potentially deleterious role of IGFBP-2 on bone density in aging men and women.
    Amin S, Riggs BL, Atkinson EJ, Oberg AL, Melton LJ, Khosla S.
    J Bone Miner Res; 2004 Jul 25; 19(7):1075-83. PubMed ID: 15176989
    [Abstract] [Full Text] [Related]

  • 35. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
    Wilson ME.
    J Clin Endocrinol Metab; 1998 Jun 25; 83(6):2018-28. PubMed ID: 9626134
    [Abstract] [Full Text] [Related]

  • 36. Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.
    Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, Gibson MJ.
    Gynecol Endocrinol; 2005 Mar 25; 20(3):176-82. PubMed ID: 16019358
    [Abstract] [Full Text] [Related]

  • 37. Alterations in the insulin-like growth factor system during the menstrual cycle in normal women.
    Helle SI, Anker GB, Meadows KA, Holly JM, Lønning PE.
    Maturitas; 1998 Jan 12; 28(3):259-65. PubMed ID: 9571602
    [Abstract] [Full Text] [Related]

  • 38. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
    Bellantoni MF, Vittone J, Campfield AT, Bass KM, Harman SM, Blackman MR.
    J Clin Endocrinol Metab; 1996 Aug 12; 81(8):2848-53. PubMed ID: 8768841
    [Abstract] [Full Text] [Related]

  • 39. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
    Gravholt CH, Chen JW, Oxvig C, Overgaard MT, Christiansen JS, Frystyk J, Flyvbjerg A.
    Growth Horm IGF Res; 2006 Aug 12; 16(5-6):332-9. PubMed ID: 17067837
    [Abstract] [Full Text] [Related]

  • 40. The IGF-I response to very low rhGH doses is preserved in human ageing.
    Arvat E, Ceda G, Ramunni J, Lanfranco F, Aimaretti G, Gianotti L, Broglio F, Ghigo E.
    Clin Endocrinol (Oxf); 1998 Dec 12; 49(6):757-63. PubMed ID: 10209563
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.